• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者血液管理:输血医学风险管理的最佳方法。

Patient blood management: The best approach to transfusion medicine risk management.

机构信息

Department of Molecular Medicine, Legal Medicine, University of Padua, Padua, Italy.

Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia.

出版信息

Transfus Apher Sci. 2020 Aug;59(4):102779. doi: 10.1016/j.transci.2020.102779. Epub 2020 Apr 27.

DOI:10.1016/j.transci.2020.102779
PMID:32359972
Abstract

In advanced health systems it is increasingly important to offer effective medical services that have high quality and safety standards. We present an overview of the direct hazards and the indirect hazards associated with blood transfusions. Our aim is to focus on the potential medico-legal impacts of these hazards in the context of clinical risk management, incorporating the accumulating evidence from Patient Blood Management programs. The direct or deterministic hazards of transfusion refer to scenarios where the mechanisms for post transfusion damage are clearly traceable to the blood transfused in a 1:1 cause and effect manner. The indirect hazards can be defined as probabilistic and are associated with transfusion through epidemiological studies. The implementation of Patient Blood Management programs demonstrates that the use of a blood transfusion is not always necessary or unavoidable but can be considered modifiable. Review of the literature confirms that transfusion should not be the default option to manage anemia or blood loss. Instead, accumulating evidence demonstrates that a patient-centred, proactive approach to managing a patient's own blood is the new standard of care. It thus follows, an adverse transfusion event, where the transfusion was avoidable through the application of patient blood management, may constitute a profile for medical professional medical negligence. In an effort to maximise patient safety, transfusion medicine practice culture needs to shift towards a patient blood management approach, with hospitals implementing it as an important tool to minimize the risks of allogeneic blood transfusion.

摘要

在先进的医疗体系中,提供高质量、安全标准的医疗服务变得愈发重要。我们概述了输血相关的直接危害和间接危害。我们旨在关注这些危害在临床风险管理背景下潜在的医学法律影响,同时整合患者血液管理项目中积累的证据。输血的直接或确定性危害是指输血后损伤的机制可以明确追溯到以 1:1 的因果关系输注的血液的情况。间接危害可以定义为概率性的,与通过流行病学研究进行的输血相关。患者血液管理项目的实施表明,输血并不总是必要或不可避免的,而是可以被认为是可改变的。文献回顾证实,输血不应该成为治疗贫血或失血的默认选择。相反,越来越多的证据表明,以患者为中心、主动管理患者自身血液的方法是新的护理标准。因此,如果通过应用患者血液管理可以避免输血,而发生了不良输血事件,则可能构成医疗专业人员医疗过失的特征。为了最大程度地提高患者安全性,输血医学实践文化需要向患者血液管理方法转变,医院将其作为减少异体输血风险的重要工具。

相似文献

1
Patient blood management: The best approach to transfusion medicine risk management.患者血液管理:输血医学风险管理的最佳方法。
Transfus Apher Sci. 2020 Aug;59(4):102779. doi: 10.1016/j.transci.2020.102779. Epub 2020 Apr 27.
2
Society for the advancement of blood management administrative and clinical standards for patient blood management programs. 4th edition (pediatric version).血液管理促进协会患者血液管理项目的行政和临床标准。第4版(儿科版)。
Paediatr Anaesth. 2019 Mar;29(3):231-236. doi: 10.1111/pan.13574.
3
New Approaches and Trials in Pediatric Transfusion Medicine.儿科输血医学的新方法和试验。
Hematol Oncol Clin North Am. 2019 Jun;33(3):507-520. doi: 10.1016/j.hoc.2019.01.012. Epub 2019 Mar 30.
4
Patient Blood Management in the Intensive Care Unit.重症监护病房中的患者血液管理。
Transfus Med Rev. 2017 Oct;31(4):264-271. doi: 10.1016/j.tmrv.2017.07.007. Epub 2017 Jul 31.
5
Patient Blood Management Bundles to Facilitate Implementation.促进实施的患者血液管理综合措施
Transfus Med Rev. 2017 Jan;31(1):62-71. doi: 10.1016/j.tmrv.2016.05.012. Epub 2016 May 28.
6
[Patient blood management].[患者血液管理]
Transfus Clin Biol. 2016 Nov;23(4):175-184. doi: 10.1016/j.tracli.2016.08.008. Epub 2016 Sep 14.
7
[Medico-legal and management issues in patient blood management era.].[患者血液管理时代的法医学与管理问题。]
Recenti Prog Med. 2023 Dec;114(12):730-734. doi: 10.1701/4142.41390.
8
The three-pillar matrix of patient blood management--an overview.患者血液管理的三支柱矩阵概述。
Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):69-84. doi: 10.1016/j.bpa.2013.02.002.
9
Adverse blood transfusion outcomes: establishing causation.不良输血结局:确定病因。
Transfus Med Rev. 2011 Apr;25(2):89-101. doi: 10.1016/j.tmrv.2010.11.001. Epub 2011 Feb 23.
10
Administration of blood transfusions to adults in general hospital settings: a review of the literature.综合医院环境中成人输血管理:文献综述
J Clin Nurs. 2001 Mar;10(2):161-70. doi: 10.1046/j.1365-2702.2001.00444.x.

引用本文的文献

1
The Clinical and Medico-Legal Aspects in the Challenge of Transfusion-Free Organ Transplants: A Scoping Review.无输血器官移植挑战中的临床与法医学问题:一项范围综述
J Clin Med. 2025 Aug 1;14(15):5444. doi: 10.3390/jcm14155444.
2
Patient Blood Management in Pediatric Patients: Current Strategies and Future Perspectives.儿科患者的患者血液管理:当前策略与未来展望
Turk J Haematol. 2025 Aug 29;42(3):170-180. doi: 10.4274/tjh.galenos.2025.2025.0301. Epub 2025 Aug 12.
3
Pre-treatment anemia in head and neck cancer: risk factors, subtypes, and survival outcomes.
头颈癌的治疗前贫血:危险因素、亚型及生存结果
Front Oncol. 2025 Jun 25;15:1577901. doi: 10.3389/fonc.2025.1577901. eCollection 2025.
4
Contact activation of coagulation in newly inserted indwelling catheters.新插入的留置导管中凝血的接触激活。
Sci Rep. 2025 Jun 3;15(1):19378. doi: 10.1038/s41598-025-04181-3.
5
Blood Product Management: A Comprehensive Analysis in a Trauma Center Hospital.血液制品管理:创伤中心医院的综合分析
Arch Iran Med. 2025 Feb 1;28(2):107-111. doi: 10.34172/aim.31324.
6
When innovation meets patient blood management - a new way to see bleeding.当创新遇上患者血液管理——一种看待出血的新方式。
Hematol Transfus Cell Ther. 2025 Jan-Mar;47(1):103691. doi: 10.1016/j.htct.2024.07.002. Epub 2024 Sep 7.
7
No evidence for liberal transfusion in acute myocardial infarction.急性心肌梗死中无放宽输血指征的证据。
Blood Transfus. 2024 Jul 7;22(4):312-315. doi: 10.2450/BloodTransfus.819.
8
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy.血浆衍生药品短缺:接下来会怎样?意大利关于其原因及应对政策的叙述性文献综述
Front Pharmacol. 2024 May 6;15:1375891. doi: 10.3389/fphar.2024.1375891. eCollection 2024.
9
Patient Blood Management and Its Role in Supporting Blood Supply.患者血液管理及其在支持血液供应中的作用。
J Blood Med. 2023 Nov 30;14:595-611. doi: 10.2147/JBM.S387322. eCollection 2023.
10
A Potential Indicator for Assessing Patient Blood Management Standard Implementation.一种用于评估患者血液管理标准实施情况的潜在指标。
Healthcare (Basel). 2023 Aug 8;11(16):2233. doi: 10.3390/healthcare11162233.